Introduction Gaucher disease type 3 (GD3) is a genetic, progressive lysosomal storage disorder characterized by visceral manifestations and chronic neurologic symptoms including horizontal ophthalmoplegia/supranuclear gaze palsy, ataxia and dystonia (1). Existing therapies like enzyme replacement (ERT) and substrate reduction therapy (SRT) are effe
2 Reached
Pancytopenia, a rare presentation of hyperthyroidism
826 Reached2 Comments
Male with Urethral Bleeding due to Insertion of Telephone Wire in Urethra
2465 Reached4 Comments6 Likes
Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes
Young Girl Presented with Irritability and Abnormal Behavior
2249 Reached11 Comments5 Likes
FOURIER Trial: Efficacy of Evolocumab in Managing Cardiovascular Events
563 Reached3 Comments